ArticleInternational journal of clinical oncology2024

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.

Hasan Çağrı Yıldırım et al.PubMed ↗Publisher ↗

No numbers read from the abstract.